/
IRADIMED CORPORATION ( IRadimed , the Company, we, us, our or similar terms) develops, manufactures, markets and distributes Magnetic Resonance Imaging ( MRI ) compatible medical devices and related accessories, disposables and services relating to them. We were originally incorporated in Oklahoma under the name IRI Development, Inc. in 1992, and we merged our Oklahoma corporation into…
Margins and capital returns are both well above average: 31.20% operating margin, ROIC at 22.32%. Consistent with durable pricing power, though that alone doesn't make it a buy.
Revenue grew 14.4%, still solid.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$86M
▲ +14.4% YoY
Net Income (TTM)
$24M
▲ +16.9% YoY
Op. Margin
32.40%
▲ +1.2pp YoY
ROIC
22.17%
▲ +1.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$24M
▼ -2.5% YoY
Op. Cash Flow (TTM)
$29M
▼ -2.6% YoY
Net Debt
-$56M
Net Cash Position
Cash & Equiv.
$56M
5Y CAGR: +21.5%
5Y CAGR: +26.2%
Continue Research